FFCP PHASE1:Mm9::chr13:27445995..27446000,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=56|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr13:27445995..27446000,+|id=chr13:27445995..27446000,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005631!3.65e-65!3;UBERON:0000478!3.65e-65!3;UBERON:0000158!3.65e-65!3;UBERON:0005795!1.60e-49!4;UBERON:0000995!1.60e-49!4;UBERON:0001987!2.75e-44!2;UBERON:0003124!2.75e-44!2;UBERON:0004340!2.75e-44!2;UBERON:0003975!7.27e-40!5;UBERON:0003134!2.39e-25!8;UBERON:0006834!5.07e-23!1;UBERON:0004175!1.19e-22!9;UBERON:0000474!1.19e-22!9;UBERON:0000305!1.39e-22!1;UBERON:0003100!1.00e-18!11;UBERON:0003133!4.35e-09!24;UBERON:0004923!4.94e-09!24;UBERON:0005156!1.87e-08!26;UBERON:0000990!1.87e-08!26;UBERON:0004871!1.88e-08!3;UBERON:0007023!1.20e-07!51|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.63212099352905,0.42366414172764,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.563047426353546,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr13:27445995..27446000,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=56 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:27445995..27446000,+ | |||
|description=CAGE_peak_at_chr13:27445995..27446000,+ | |||
|id=chr13:27445995..27446000,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005631!3.65e-65!3;UBERON:0000478!3.65e-65!3;UBERON:0000158!3.65e-65!3;UBERON:0005795!1.60e-49!4;UBERON:0000995!1.60e-49!4;UBERON:0001987!2.75e-44!2;UBERON:0003124!2.75e-44!2;UBERON:0004340!2.75e-44!2;UBERON:0003975!7.27e-40!5;UBERON:0003134!2.39e-25!8;UBERON:0006834!5.07e-23!1;UBERON:0004175!1.19e-22!9;UBERON:0000474!1.19e-22!9;UBERON:0000305!1.39e-22!1;UBERON:0003100!1.00e-18!11;UBERON:0003133!4.35e-09!24;UBERON:0004923!4.94e-09!24;UBERON:0005156!1.87e-08!26;UBERON:0000990!1.87e-08!26;UBERON:0004871!1.88e-08!3;UBERON:0007023!1.20e-07!51 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.63212099352905,0.42366414172764,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.563047426353546,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:27445995..27446000,+ | |||
}} |
Latest revision as of 20:45, 5 August 2015
Short description: | p@chr13:27445995..27446000, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr13:27445995..27446000, + |
Coexpression cluster: | MCL_coexpression_mm9:56 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
placenta | 4.52e-44 | 2 |
chorion | 4.52e-44 | 2 |
allantois | 4.52e-44 | 2 |
extraembryonic membrane | 5.61e-30 | 3 |
extraembryonic structure | 5.61e-30 | 3 |
membranous layer | 5.61e-30 | 3 |
embryonic uterus | 6.52e-23 | 4 |
uterus | 6.52e-23 | 4 |
internal female genitalia | 1.16e-18 | 5 |
female reproductive organ | 2.93e-12 | 8 |
internal genitalia | 4.56e-11 | 9 |
female reproductive system | 4.56e-11 | 9 |
female organism | 2.51e-09 | 11 |